DeepMed Research

UKC Ljubljana

🇸🇮Slovenia

Country: 🇸🇮Slovenia

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Comparison of Two Anaesthetics on Brain During Brain Tumour Surgery

Phase 1

Completed

Conditions: Inflammation

Interventions: Drug: Propofol
Drug: Sevoflurane

First Posted Date: 2014-09-01

Last Posted Date: 2014-09-01

Lead Sponsor: University Medical Centre Ljubljana

Target Recruit Count: 40

Registration Number: NCT02229201

Locations: 🇸🇮
University Medical Centre Ljubljana, Ljubljana, Slovenia

Antiplatelet Therapy After Cardiac Arrest

Phase 4

Completed

Conditions: Postresuscitation Syndrome
Cardiac Arrest
Myocardial Infarction (ST-Elevation Myocardial Infarction and Non-ST-Elevation Myocardial Infarction)

Interventions: Drug: Clopidogrel
Drug: Ticagrelor

First Posted Date: 2014-08-25

Last Posted Date: 2019-02-27

Lead Sponsor: University Medical Centre Ljubljana

Target Recruit Count: 57

Registration Number: NCT02224274

Locations: 🇸🇮
University Medical Centre Ljubljana, Ljubljana, Slovenia

The Impact of Simultaneous Presence of Viral and Bacterial Pathogens on Therapy and Course of Severe Pneumonia

Conditions: Hospital Acquired Pneumonia
Community Acquired Pneumonia
Ventilator Associated Pneumonia

First Posted Date: 2014-07-29

Last Posted Date: 2014-07-29

Lead Sponsor: University Medical Centre Ljubljana

Target Recruit Count: 150

Registration Number: NCT02203110

Locations: 🇸🇮
Intensive Care Unit. Department of Infectious Diseases, Umiversity Medical Centre Ljubljana, Japljeva 2, Ljubljana, Slovenia

Inflammation After One Lung Ventilation

Phase 1

Completed

Conditions: Inflammation

Interventions: Drug: Sevoflurane
Drug: Propofol

First Posted Date: 2014-07-11

Last Posted Date: 2014-07-11

Lead Sponsor: University Medical Centre Ljubljana

Target Recruit Count: 40

Registration Number: NCT02188407

Locations: 🇸🇮
UMCLjubljana, CD of Anaesthesiology and Intensive Therapy, Ljubljana, Slovenia

PDE-4 Inhibitor Roflumilast and GLP-1 Agonist Liraglutide in Polycystic Ovary Syndrome

Phase 4

Completed

Conditions: PCOS
Obesity

Interventions: Drug: metformin
Drug: liraglutide
Drug: roflumilast

First Posted Date: 2014-07-10

Last Posted Date: 2014-07-10

Lead Sponsor: University Medical Centre Ljubljana

Target Recruit Count: 45

Registration Number: NCT02187250

Locations: 🇸🇮
University Medical Center Ljubljana, Ljubljana, Slovenia

Treatment of Morbidly Obese Adolescent With a Duodena-jejunal Liner

Phase 3

Completed

Conditions: Diabetes
Metabolic Syndrome
Obesity

Interventions: Device: Duodena-jejunal liner

First Posted Date: 2014-07-08

Last Posted Date: 2020-07-10

Lead Sponsor: University Medical Centre Ljubljana

Target Recruit Count: 22

Registration Number: NCT02183935

Locations: 🇸🇮
UMC Ljubljana, Ljubljana, Slovenia

Laboratory Characteristics in Chronic Atrophic Acrodermatitis

Not Applicable

Conditions: Chronic Atrophic Acrodermatitis

Interventions: Drug: doxycycline orally, 100 mg, bid, 14 days
Drug: doxycycline orally, 100 mg, bid, 28 days

First Posted Date: 2014-05-26

Last Posted Date: 2018-05-04

Lead Sponsor: University Medical Centre Ljubljana

Target Recruit Count: 50

Registration Number: NCT02147262

Locations: 🇸🇮
UMC Ljubljana, Department of Infectious Diseases, Ljubljana, Slovenia

Cytokines and Chemokines in Erythema Migrans

Not Applicable

Conditions: Erythema Migrans

Interventions: Drug: antibiotic treatment

First Posted Date: 2014-05-26

Last Posted Date: 2019-04-22

Lead Sponsor: University Medical Centre Ljubljana

Target Recruit Count: 150

Registration Number: NCT02147249

Locations: 🇸🇮
UMC Ljubljana, Department of Infectious Diseases, Ljubljana, Slovenia

Culture Media for Borrelia Burgdorferi Sensu Lato

Not Applicable

Completed

Conditions: Erythema Migrans

Interventions: Other: MKP media
Other: BSK-H media

First Posted Date: 2014-05-23

Last Posted Date: 2015-06-30

Lead Sponsor: University Medical Centre Ljubljana

Target Recruit Count: 235

Registration Number: NCT02145754

Locations: 🇸🇮
UMC Ljubljana, Department of Infectious Diseases, Ljubljana, Slovenia

A Pilot Trial of Ranolazine to Treat Patients With Dilated Cardiomyopathy

Phase 2

Completed

Conditions: Dilated Cardiomyopathy

Interventions: Drug: Ranolazine

First Posted Date: 2014-05-08

Last Posted Date: 2021-04-28

Lead Sponsor: University Medical Centre Ljubljana

Target Recruit Count: 10

Registration Number: NCT02133911

Locations: 🇸🇮
Advanced Heart Failure and Transplantation Programme, University Medical Center Ljubljana, Slovenia, Ljubljana, Slovenia

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy